Switching Between Second-Generation Antipsychotics in Patients with Schizophrenia and Schizoaffective Disorder: 10-Year Cohort Study in Brazil

Objective: Switching between second-generation antipsychotics (SGAs) is a common clinical practice in the treatment of schizophrenia and schizoaffective disorders due to differences in the drugs’ tolerability and safety profiles as well as the challenge of obtaining an ideal response. However, the f...

Descripción completa

Detalles Bibliográficos
Autores principales: Fulone, Izabela, Silva, Marcus Tolentino, Lopes, Luciane Cruz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201606/
https://www.ncbi.nlm.nih.gov/pubmed/34135752
http://dx.doi.org/10.3389/fphar.2021.638001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201606/
https://www.ncbi.nlm.nih.gov/pubmed/34135752
http://dx.doi.org/10.3389/fphar.2021.638001

Ejemplares similares